# Orphenadrine citrate

NDC: 0641-6182
Generic name: Orphenadrine citrate
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20030428

FDA application: ANDA040463

## Active ingredients

- ORPHENADRINE CITRATE: 60 mg/2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0641-6182"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0641-6182
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ed406e8a-ec00-4711-ae2b-3c5af4f15438